Companion Diagnostics Market Outlook 2025–2029: Trends by Application, Tech & Funding
The “Companion Diagnostic Markets 2025-2029: The Future of Diagnostics by Application, Technology and Funding with Executive & Consultant Guides” report has been added to ResearchAndMarkets.com’s offering. Companion Diagnostics are changing the diagnostics industry. Whole new markets are emerging. Diagnostic and Therapeutic partnerships. Find out…
FPT Proposes Public-Private Partnership Model to Develop Vietnam’s Digital Healthcare Ecosystem
-Global IT services provider FPT and Pharma Group jointly hosted the Healthcare Innovation Forum – HIF 2025. The event served as a multi-stakeholder dialogue platform with a spotlight on breakthrough innovations in science, technology, and AI to accelerate healthcare advancements…
Quantum Health Signs Agreement to Acquire Embold Health
Quantum Health (“Quantum”), the creator of healthcare navigation, has signed a definitive agreement to acquire Embold Health (“Embold”), a leading physician-led healthcare technology company. The transaction is expected to close within the next 14 days, subject to customary closing conditions and…
Altera Digital Health Collaborates With MCAG Amid $2.8B Blue Cross Blue Shield Provider Settlement
Altera Digital Health, a global healthcare IT leader, today announced it has entered into an agreement with Managed Care Advisory Group, Inc. (MCAG), one of the largest revenue recovery consulting firms, to bring MCAG’s class action lawsuit recovery services to hospitals and…
LivaNova Seeks CMS Reconsideration for VNS Coverage in Depression
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced it has initiated the process with the U.S. Centers for Medicare and Medicaid Services (CMS) to seek reconsideration of national Medicare coverage for VNS Therapy™ in unipolar patients with…
TriSalus Life Sciences Announces the Launch of the TriNav FLX Infusion System
TriSalus Life Sciences®, Inc. (“TriSalus” or the “Company”) (Nasdaq: TLSI), which seeks to transform outcomes for patients with solid tumors by integrating our innovative delivery technology with standard-of-care therapies and our investigational immunotherapy, is excited to announce the launch of…
SetPoint Medical Appoints Tyler Binney to Its Board of Directors
SetPoint Medical, a clinical-stage healthcare company dedicated to people living with chronic autoimmune diseases, today announced the appointment of Tyler Binney to its Board of Directors. With a career built around scaling disruptive MedTech platforms, Binney brings over two decades…
Blue Cross and Blue Shield of Louisiana to Cover Kerecis Fish Skin Grafts for Diabetic Foot Ulcers
Kerecis, the company pioneering the use of sustainably sourced fish skin in cellular therapy and tissue regeneration, announces that Blue Cross and Blue Shield of Louisiana (BCBSLA) has added Kerecis MariGen® to its list of covered treatments for diabetic foot…
Align Technology Funds Global Dental and Orthodontic Research
-Align Technology, Inc. (“Align”) (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced the award of…
Hologic Joins NEST Governance Committee to Advance the Use of Real-World Data in Medical Device Evaluation
The National Evaluation System for health Technology (NEST), an initiative of the Medical Device Innovation Consortium (MDIC), is pleased to welcome Hologic, a leading global medical device and diagnostic company, to its Governance Committee. This appointment reflects Hologic’s commitment to…
NUBURU Accelerates M&A Strategy with $100 Million Flexible Growth Capital
NUBURU, Inc. (NYSE American: BURU), a leader in high-power blue laser technology under a pivotal transformation plan, entered into a standby equity purchase agreement (the “Agreement”) with YA II PN, Ltd. (the “Investor”) under which the company has the option,…
Actym Therapeutics Announces Issuance of US Patents
Actym Therapeutics, a clinical-stage therapeutic product development and platform company, announced the issuance of US patent Nos. 12,201,653 and 12,226,439 by the United States Patent and Trademark Office. These patents pertain to Actym’s novel therapeutic modality, which utilizes engineered bacteria…